{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:51:08Z","timestamp":1787169068851,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian Dermatol Online J"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/idoj.idoj_6_23","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T09:37:54Z","timestamp":1682588274000},"page":"361","source":"Crossref","is-referenced-by-count":7,"title":["Vitiligo: Correlation with cytokine profiles and its role in novel therapeutic strategies: A case\u2013control study"],"prefix":"10.4103","volume":"14","author":[{"given":"HariKishan","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Naveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Somanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/2229-5178.375185-1","unstructured":"Prasad D, Kumaran S. Depigmentary and hypopigmentary disorders. In: Griffiths CEM, Barker J, Bleoker T, Calmers R. Creamer D, editors. Rooks Textbook of Dermatology. 9th ed. John Wiley and Sons Ltd., 2016. p. 1343-4."},{"key":"key-10.4103\/2229-5178.375185-2","first-page":"526","article-title":"Vitiligo: Pathomechanisms and genetic polymorphism of susceptible genes","author":"Shajil","year":"2006","journal-title":"Indian J Exp Biol"},{"key":"key-10.4103\/2229-5178.375185-3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/jocd.12517","article-title":"Cytokine profile (IL-2, IL-6, IL-17, IL-22, and TNF-\u03b1) in vitiligo\u2014New insight into pathogenesis of disease","author":"Sushama","year":"2019","journal-title":"J Cosmet Dermatol"},{"key":"key-10.4103\/2229-5178.375185-4","first-page":"223ra23","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","author":"Rashigi","year":"2014","journal-title":"Sci Transl Med"},{"key":"key-10.4103\/2229-5178.375185-5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003362","article-title":"Immunological pathomechanisms in vitiligo","author":"Kemp","year":"2001","journal-title":"Exp Rev Mol Med"},{"key":"key-10.4103\/2229-5178.375185-6","first-page":"2220","article-title":"Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients","author":"van","year":"2009","journal-title":"J Invest Dermat"},{"key":"key-10.4103\/2229-5178.375185-7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/08830189809084493","article-title":"Cytokines in autoimmune disorders","author":"Feldmann","year":"1998","journal-title":"Int Rev Immunol"},{"key":"key-10.4103\/2229-5178.375185-8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1034\/j.1600-0749.2002.1o049.x","article-title":"New insights into the pathogenesis of vitiligo: Imbalance of epidermal cytokines at sites of lesions","author":"Moretti","year":"2002","journal-title":"Pigment Cell Res"},{"key":"key-10.4103\/2229-5178.375185-9","first-page":"19","article-title":"Melanocytorrhagy and apoptosis in vitiligo: Connecting jigsaw pieces","author":"Kumar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol","ISSN":"https:\/\/id.crossref.org\/issn\/0378-6323","issn-type":"print"},{"key":"key-10.4103\/2229-5178.375185-10","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0738-081X(89)90063-1","article-title":"Serum antibodies in vitiligo patients","author":"Bystryn","year":"1989","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2229-5178.375185-11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/1523-1747.ep12709595","article-title":"Regulation of human melanocyte growth, dendricity, and melanizationby keratinocyte derived factors","author":"Gordon","year":"1989","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.375185-12","first-page":"177","article-title":"The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA irradiation","author":"Kondo","year":"1999","journal-title":"J Invset Dermatol"},{"key":"key-10.4103\/2229-5178.375185-13","doi-asserted-by":"crossref","unstructured":"Ala Y, Pasha MK, Rao RN, Komaravalli PL, Jahan P. Association of IFN-\u03b3: IL-10 Cytokine Ratio with Nonsegmentalvitiligo Pathogenesis. Hindawi Publishing Corporation Autoimmune Diseases; 2015. p. 8.","DOI":"10.1155\/2015\/423490"},{"key":"key-10.4103\/2229-5178.375185-14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/pcmr.12105","article-title":"Decreased regulatory T-cells and CD4+\/CD8+ ratio correlate with disease onset and progression in patients with generalized vitiligo","author":"Dwivedi","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"key-10.4103\/2229-5178.375185-15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1089\/jir.2012.0171","article-title":"Involvement of interferon-gamma genetic variants and intercellular adhesion molecule-1 in onset and progression of generalized Vitiligo","author":"Dwivedi","year":"2013","journal-title":"J Interferon Cytokine Res"},{"key":"key-10.4103\/2229-5178.375185-16","first-page":"233","article-title":"Moulation of melanocyte intercellular adhesion molecule-1 by immune cytokines","author":"Yohn","year":"1000","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.375185-17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2011.377","article-title":"IFN-\u03b3, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of smythline chickens","author":"Shi","year":"2012","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.375185-18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2013.05.005","article-title":"T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo","author":"Tembhre","year":"2013","journal-title":"Clin Chim Acta"},{"key":"key-10.4103\/2229-5178.375185-19","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","article-title":"Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus","author":"Taher","year":"2009","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2229-5178.375185-20","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/10715762.2017.1402303","article-title":"Levels of oxidative damage and proinflammatory cytokines are enhanced in patients with active vitiligo","author":"Mitra","year":"2017","journal-title":"Free Radic Res"},{"key":"key-10.4103\/2229-5178.375185-21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-a, and IFNc in Vitiligo patients","author":"Singh","year":"2012","journal-title":"Indian J Dermatol","ISSN":"https:\/\/id.crossref.org\/issn\/0019-5154","issn-type":"print"},{"key":"key-10.4103\/2229-5178.375185-22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/1523-1747.ep12289743","article-title":"Alterations in IL-6, IL-8, GM-CSF, TNF-alpha, and IFN-gamma release by peripheral mononuclear cells in patients with active vitiligo","author":"Yu","year":"1997","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2229-5178.375185-23","first-page":"408","article-title":"Changes in sICAM-1 and GM-CSF levels in skin tissue fluid and expression of IL-6, IL-17 and TNF-a in blood of patients with vitiligo","author":"Yang","year":"2018","journal-title":"Exp Ther Med"},{"key":"key-10.4103\/2229-5178.375185-24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13685538.2018.1482487","article-title":"The relationship between circulating testosterone and inflammatory cytokines in men","author":"Mohamad","year":"2019","journal-title":"Aging Male"},{"key":"key-10.4103\/2229-5178.375185-25","doi-asserted-by":"crossref","first-page":"e107020","DOI":"10.1371\/journal.pone.0107020","article-title":"Association of neuropeptide Y (NPY), interleukin-1B (IL1B) genetic variants and correlation of IL1B transcript levels with vitiligo susceptibility","author":"Laddha","year":"2014","journal-title":"PLoS One"},{"key":"key-10.4103\/2229-5178.375185-26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cyto.2016.12.014","article-title":"Increased systemic and epidermal levels of IL-17A and IL-1\u03b2 promotes progression of non-segmental vitiligo","author":"Bhardwaj","year":"2017","journal-title":"Cytokine"},{"key":"key-10.4103\/2229-5178.375185-27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-\ufffdinducible inhibitors of signalling","author":"Starr","year":"1997","journal-title":"Nature"}],"container-title":["Indian Dermatology Online Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:46:59Z","timestamp":1787165219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/idoj.idoj_6_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"alternative-id":["375185"],"URL":"https:\/\/doi.org\/10.4103\/idoj.idoj_6_23","relation":{},"ISSN":["2229-5178"],"issn-type":[{"value":"2229-5178","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}